Studies that measured hepcidin concentration in the circulation of COVID-19 patients gave conflicting results, with most studies demonstrating elevated hepcidin concentrations [22,23,24,25], but its decreased concentrations in critically ill patients compared to healthy controls were also reported [26]. The gene discussed is HAMP; the disease is COVID-19.